| 1 |
33581289 | Carbonyl reduction pathway in hepatic in vitro metabolism of anthracyclines: Impact of structure on biotransformation rate. | 2021 May 15 |
3 |
| 2 |
33774021 | Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy. | 2021 Jul 1 |
1 |
| 3 |
32621953 | The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression. | 2020 Oct 28 |
2 |
| 4 |
30611789 | Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition. | 2019 Feb 25 |
2 |
| 5 |
26563179 | Risk factors for anthracycline-associated cardiotoxicity. | 2016 May |
3 |
| 6 |
25541467 | Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1. | 2015 Jun 5 |
1 |
| 7 |
25549925 | Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1). | 2015 Mar |
2 |
| 8 |
26068795 | Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1. | 2015 Jul 21 |
3 |
| 9 |
26415702 | The modulation of carbonyl reductase 1 by polyphenols. | 2015 |
2 |
| 10 |
23247010 | Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2. | 2013 Feb 25 |
3 |
| 11 |
20670211 | Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia. | 2010 Dec |
2 |
| 12 |
20729274 | Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome. | 2010 Dec |
4 |
| 13 |
19022938 | Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors. | 2009 Feb |
1 |
| 14 |
19204081 | Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. | 2009 May |
1 |
| 15 |
18449627 | Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER). | 2008 Jul |
1 |
| 16 |
17344335 | A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity. | 2007 Jun |
2 |
| 17 |
15799708 | An unbiased cell morphology-based screen for new, biologically active small molecules. | 2005 May |
1 |